APC and cancer: We demonstrate that miR-31 promotes tumor development using several models, including cancer cells xenografting, AOM- and DSS- induced inflammation-driven tumors, and Apc-loss driven tumors, characterized by activated Wnt, and repressed BMP/TGFβ signalings.